|
Aug, 2009 | Pages : 155 | Price : US$ 1800.00 |
| The global protein therapeutics market is expected to grow at a CAGR of around 12% during 2010-2012. At present, the market is characterized by high cost treatments therapy and healthcare insurance. |
| |
|
Aug, 2009 | Pages : 90 | Price : US$ 1400.00 |
| The number of diabetic patients in the world is estimated to reach more than 250 Million in 2008. The global insulin market is forecasted to grow at a CAGR of around 15% during 2010-2012. |
| |
|
Jun, 2009 | Pages : 150 | Price : US$ 2000.00 |
| The global vaccine market is expected to register revenues in excess of US$ 34 Billion by 2012. |
| |
|
May, 2009 | Pages : 60 | Price : US$ 800.00 |
| The number of Clinical trials conducted in Russia increased 9% over 2007. The government invested US$ 3.4 Billion to improve the utilization of resources in the sector. |
| |
|
May, 2009 | Pages : 50 | Price : US$ 800.00 |
| The stem cell therapy market reported a CAGR growth of around 18% in a short period spanning from 2005 to 2008. |
| |
|
Jan, 2009 | Pages : 50 | Price : US$ 800.00 |
| Between 2005 and 2008, the Japanese generics market grew at a CAGR of around 7.5% to register ¥ 333 Billion (US$ 3.5 Billion) in revenue. |
| |
|
Dec, 2008 | Pages : 80 | Price : US$ 1100.00 |
| By 2012, it’s expected that more than two billion people will be overweight and 600 Million will be obese, representing immense opportunities for both the markets. |
| |
|
Nov, 2008 | Pages : 60 | Price : US$ 799.00 |
| The Ukraine market is expected to grow strongly, exceeding US$ 4.5 Billion in revenues by 2012, despite country’s unstable political environment. |
| |
|
Sep, 2008 | Pages : 100 | Price : US$ 1000.00 |
| Total healthcare spending in the US is expected to grow at a CAGR of 7% (2007-2012). Around 122 Million Americans are expected to spend over US$ 414 Billion on cardiovascular diseases by 2012. |
| |
|
Sep, 2008 | Pages : 115 | Price : US$ 1100.00 |
| The Russian pharmaceutical market grew 16% in 2007 as compared to 2006. The Russian pharmaceutical market is forecasted to grow at a CAGR of 14.36% by 2012. |
| |
|
|
